BBVA USA’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$60K Buy
1,221
+10
+0.8% +$542 ﹤0.01% 623
2021
Q2
$69K Buy
+1,211
New +$70.8K ﹤0.01% 621

Other funds holding CAH

BBVA USA's CAH Position: Q3 2021 in Review

BBVA USA increased its Cardinal Health (CAH) stake by 0.83% in Q3 2021, buying an estimated $542 and bringing the position to 1,221 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #623.

BBVA USA first reported a position in CAH in Q2 2021 and has held it in 2 quarters since. The position peaked at $69K in Q2 2021. 748 funds tracked by Wall St. Rank hold CAH as of Q3 2021.

  • BBVA USA held 1,221 shares of Cardinal Health worth $60K as of Q3 2021.
  • BBVA USA bought 10 Cardinal Health shares in Q3 2021, an estimated $542.
  • Cardinal Health made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #623 holding.
  • BBVA USA first reported a position in Cardinal Health in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Cardinal Health position peaked at $69K in Q2 2021.
  • 748 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.